Antibiotic Overprescribing among Neonates and Children Hospitalized with COVID-19 in Pakistan and the Implications
Open Access
- 24 March 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (4), 646
- https://doi.org/10.3390/antibiotics12040646
Abstract
There are concerns with excessive antibiotic prescribing among patients admitted to hospital with COVID-19, increasing antimicrobial resistance (AMR). Most studies have been conducted in adults with limited data on neonates and children, including in Pakistan. A retrospective study was conducted among four referral/tertiary care hospitals, including the clinical manifestations, laboratory findings, the prevalence of bacterial co-infections or secondary bacterial infections and antibiotics prescribed among neonates and children hospitalized due to COVID-19. Among 1237 neonates and children, 511 were admitted to the COVID-19 wards and 433 were finally included in the study. The majority of admitted children were COVID-19-positive (85.9%) with severe COVID-19 (38.2%), and 37.4% were admitted to the ICU. The prevalence of bacterial co-infections or secondary bacterial infections was 3.7%; however, 85.5% were prescribed antibiotics during their hospital stay (average 1.70 ± 0.98 antibiotics per patient). Further, 54.3% were prescribed two antibiotics via the parenteral route (75.5%) for ≤5 days (57.5), with most being ‘Watch’ antibiotics (80.4%). Increased antibiotic prescribing was reported among patients requiring mechanical ventilation and high WBCs, CRP, D-dimer and ferritin levels (p < 0.001). Increased COVID-19 severity, length of stay and hospital setting were significantly associated with antibiotic prescribing (p < 0.001). Excessive antibiotic prescribing among hospitalized neonates and children, despite very low bacterial co-infections or secondary bacterial infections, requires urgent attention to reduce AMR.Keywords
This publication has 95 references indexed in Scilit:
- Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countriesThe Lancet. Global Health, 2019
- Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implicationsHospital Practice, 2019
- A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implicationsExpert Review of Anti-infective Therapy, 2019
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2018
- Pakistan's national action plan for antimicrobial resistance: translating ideas into realityThe Lancet Infectious Diseases, 2018
- Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implicationsHospital Practice, 2018
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Proceedings of the National Academy of Sciences of the United States of America, 2018
- Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaReThe Lancet Infectious Diseases, 2018
- Antibiotic stewardship in low- and middle-income countries: the same but different?Clinical Microbiology & Infection, 2017
- Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in PakistanPLOS ONE, 2016